[Consensus of Chinese experts on the multidisciplinary management of adverse reactions to antibody-drug conjugates in the treatment of lung cancer (2025 edition)].

医学 重症监护医学 肺癌 不利影响 多学科方法 疾病 癌症 肺癌的治疗 药物反应 肺 药品 呼吸道疾病 临床实习 疾病管理 靶向治疗 内科学 药物不良反应 患者安全 病态的 梅德林 生物信息学 肺病
出处
期刊:PubMed [National Institutes of Health]
卷期号:48 (6): 703-723
标识
DOI:10.3760/cma.j.cn112152-20251113-00569
摘要

Antibody-drug conjugates (ADCs) are covalently conjugated molecules composed of a monoclonal antibody, a payload, and a linker. They represent an innovative therapeutic approach that combines the precise targeting capability of target therapies with the cytotoxic effects of chemotherapeutic agents. Given the unique molecular structure of ADCs, drug-related adverse reactions have drawn a considerable attention. Based on the safety data of ADCs currently available in the field of lung cancer, the common adverse drug reactions primarily involve the digestive system, hematologic system, hepatobiliary system, pulmonary system, skin, eyes, sensory nervous system, and musculoskeletal system. Unlike other cancer types, lung cancer is characterized by complex disease subtypes and molecular pathological mechanisms, as well as diverse treatment modalities. Moreover, patients with advanced lung cancer often have comorbidities such as chronic obstructive pulmonary disease and pulmonary inflammation, making the comprehensive management of ADC-related adverse reactions even more challenging. To address this, the Precision Treatment Branch of Thoracic Oncology, Chinese Geriatric Health Association, has taken the lead in organizing a multidisciplinary panel of domestic experts in gastroenterology, dermatology, respiratory medicine, ophthalmology and oncology, to discuss and jointly formulate the "Consensus of Chinese experts on the multidisciplinary management of adverse reactions to antibody-drug conjugates in the treatment of Lung Cancer (2025 edition)". A total of 21 recommendations are proposed in this consensus, covering pre-ADC safety assessments, comprehensive monitoring and management of relevant adverse reactions during ADC treatment, patient education, and medication guidance for special populations. The consensus aims is to provide clinicians with practical guidelines for the application of ADC, thereby maximizing therapeutic benefits for patients with lung cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
champion发布了新的文献求助10
刚刚
MMP完成签到,获得积分10
刚刚
CipherSage的应助被焦一诺采纳,获得10
1秒前
1秒前
orixero的应助被勤劳的瑀采纳,获得10
1秒前
2秒前
2秒前
NengA完成签到,获得积分10
2秒前
优秀大开完成签到,获得积分10
3秒前
3秒前
df完成签到 ,获得积分10
3秒前
共享精神的应助被菘蓝采纳,获得10
3秒前
4秒前
涵雁发布了新的文献求助10
4秒前
酷波er的应助被Q52采纳,获得10
4秒前
椰子杨完成签到,获得积分10
5秒前
sun完成签到,获得积分10
5秒前
6秒前
苍岚完成签到,获得积分10
7秒前
2206714632发布了新的文献求助10
7秒前
8秒前
感动的以旋完成签到,获得积分10
8秒前
Ying发布了新的文献求助10
9秒前
椰子杨发布了新的文献求助10
9秒前
champion完成签到,获得积分20
9秒前
英俊的铭的应助被yizhiyang采纳,获得10
10秒前
10秒前
汉堡包的应助被MY采纳,获得10
11秒前
nature发布了新的文献求助10
11秒前
11秒前
11秒前
yqb发布了新的文献求助10
12秒前
哇塞的完成签到,获得积分10
12秒前
huichenggong完成签到,获得积分10
12秒前
终梦的应助被gmj采纳,获得20
13秒前
兜里有糖完成签到 ,获得积分10
13秒前
勤劳的瑀发布了新的文献求助10
13秒前
14秒前
ou发布了新的文献求助10
14秒前
合成大王南波万完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193925
求助须知:如何正确求助?哪些是违规求助? 9579945
关于积分的说明 21868504
捐赠科研通 7793568
什么是DOI,文献DOI怎么找? 3437462
关于科研通互助平台的介绍 2560923
邀请新用户注册赠送积分活动 2484250